Home / Short Term Target / Kabradg
Kabra Drugs Share Price Target - Tomorrow, Next Week & Next Month
Kabra Drugs Limited | |||
Symbol: KABRADG | |||
Price: ₹9.59 | |||
Exchange: BSE | |||
-> |
Show Table of Contents
Table of Contents
- 1: Kabra Drugs Recent Performance
- 2: Chart: Kabra Drugs Share Price Target - Tomorrow
- 3: Table: Kabra Drugs Share Price Target - Tomorrow
- 4: Summary: Kabra Drugs Share Price Prediction For Tomorrow
- 5: Chart: Kabra Drugs Share Price Target - Next Week
- 6: Table: Kabra Drugs Share Price Target - Next Week
- 7: Summary: Kabra Drugs Share Price Prediction For Next Week
- 8: Chart: Kabra Drugs Share Price Target - Next Month
- 9: Table: Kabra Drugs Share Price Target - Next Month
- 10: Summary: Kabra Drugs Share Price Prediction For Next Month
Kabra Drugs Recent Performance
Over the past 5 trading days, the value of Kabra Drugs's stock has increased by ₹0.45 (+4.92%). On 21 Oct 2024, one share was worth ₹9.14 and by 18 Nov 2024, the value jumped to ₹9.59. During this period it created a highest high of ₹9.59 and lowest low of ₹9.14.
Below Image represents line chart of daily close price of Kabra Drugs, helping you visualize how the price has changed day by day.
Chart: Kabra Drugs Share Price Target - Tomorrow
The line chart displays the Kabra Drugs daily closing prices for the past 5 trading days using a black line. The green line indicates the potential targets, while the red line shows the potential Stop-Loss (SL) levels.
For detailed target and stop loss values for Kabra Drugs shares for Mon 18 Nov 2024, see the table below.
Table: Kabra Drugs Share Price Target - Tomorrow
By analyzing Kabra Drugs stock with yesterday and past crucial price points and technical indicators we derived following targets for Tomorrow: Mon, 25 Nov, 2024!
Kabra Drugs's Levels | Value | Reason/Importance |
---|---|---|
Tomorrow Target 3 | 10.00 (+4.27%) | Price Action: Chart |
Tomorrow Target 2 | 9.81 (+2.29%) | Price Action: Chart |
Tomorrow Target 1 | 9.71 (+1.25%) | Price Action: Chart |
Current Price | 9.59 | Kabra Drugs's 1 share price as of Mon 18 Nov 2024 |
Stop Loss 1 | 9.56 (-0.32%) | Price Action: Chart |
Stop Loss 2 | 9.51 (-0.84%) | Price Action: Chart |
Stop Loss 3 | 9.45 (-1.46%) | Price Action: Chart |
Summary: Kabra Drugs Share Price Prediction For Tomorrow
Mon 18 Nov 2024: Kabra Drugs finished the day at ₹9.59, gaining ₹0.00 (+0.00%) in 1 day.
In summary, our analysis of Kabra Drugs for tomorrow predicts a rise of 1.25% to 4.27% with three potential targets T1: ₹9.71, T2: ₹9.81, T3: ₹10.00 and Stop-Loss (SL) at SL1: ₹9.56, SL2: ₹9.51, SL3: ₹9.45.
Additionally, we've identified a support level at ₹9.59 — think of this as a safety net where the price might stop falling and there's also a resistance level at ₹9.59, which is like a ceiling at which the price might have a hard time breaking through. These targets are based on our study of past trends and technical analysis using various indicators.
After looking at tomorrow's share price prediction, let's now check what next week might hold for Kabra Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Chart: Kabra Drugs Share Price Target - Next Week
The chart displays the Kabra Drugs weekly closing prices for the past 25 trading weeks using a black line. It also shows three targets using a green line, while the red line shows the potential Stop-Loss (SL) levels for next week.
For detailed target and stop loss values for Kabra Drugs shares for next week, see the table below.
Table: Kabra Drugs Share Price Target - Next Week
By analyzing Kabra Drugs stock with yesterday and past crucial price points and technical indicators we derived following targets for the next week!
Kabra Drugs's Levels | Value | Reason/Importance |
---|---|---|
Next Week Target 3 | 9.96 (+3.85%) | Custom Fibonacci Extension Lvl 82% |
Next Week Target 2 | 9.82 (+2.39%) | Fibonacci Extension Level 150% |
Next Week Target 1 | 9.70 (+1.14%) | Fibonacci Extension Level 123.6% |
Current Price | 9.59 | Kabra Drugs's 1 share price as of Mon 18 Nov 2024 |
Stop Loss 1 | 9.56 (-0.32%) | Price Action: Chart |
Stop Loss 2 | 9.42 (-1.78%) | Fibonacci Retracement Level 38.2% |
Stop Loss 3 | 9.27 (-3.34%) | Fibonacci Retracement Level 71.8% |
Summary: Kabra Drugs Share Price Prediction For Next Week
As of Mon 18 Nov 2024, Kabra Drugs share price stands at ₹9.59, gaining ₹0.00 (+0.00%) in this week.
In summary, our analysis of Kabra Drugs for next week predicts a rise of 1.14% to 3.85% with three potential targets T1: ₹9.70, T2: ₹9.82, T3: ₹9.96 and Stop-Loss (SL) at SL1: ₹9.56, SL2: ₹9.42, SL3: ₹9.27.
Additionally, we've identified a support level at ₹9.59 — think of this as a safety net where the price might stop falling and there's also a resistance level at ₹9.59, which is like a ceiling at which the price might have a hard time breaking through.
After looking at tomorrow's and next week's share price prediction, let's now check what next month might hold for Kabra Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Chart: Kabra Drugs Share Price Target - Next Month
The chart displays the Kabra Drugs monthly closing prices for the past 25 months using a black line. It also shows three targets using green line, while the red line shows the potential Stop-Loss (SL) levels.
For detailed target and stop loss values for Kabra Drugs shares for next month, see the table below.
Table: Kabra Drugs Share Price Target - Next Month
By analyzing Kabra Drugs stock with yesterday and past crucial price points and technical indicators we derived following targets for Next Month!
Kabra Drugs's Levels | Value | Reason/Importance |
---|---|---|
Next Month Target 3 | 9.96 (+3.85%) | Custom Fibonacci Extension Lvl 82% |
Next Month Target 2 | 9.82 (+2.39%) | Fibonacci Extension Level 150% |
Next Month Target 1 | 9.70 (+1.14%) | Fibonacci Extension Level 123.6% |
Current Price | 9.59 | Kabra Drugs's 1 share price as of Mon 18 Nov 2024 |
Stop Loss 1 | 9.57 (-0.21%) | Price Action: Chart |
Stop Loss 2 | 9.42 (-1.78%) | Fibonacci Retracement Level 38.2% |
Stop Loss 3 | 9.27 (-3.34%) | Fibonacci Retracement Level 71.8% |
Summary: Kabra Drugs Share Price Prediction For Next Month
As of Mon 18 Nov 2024, Kabra Drugs share price stands at ₹9.59, gaining ₹0.45 (+4.92%) in this month.
In summary, our analysis of Kabra Drugs for next month predicts a rise of 1.14% to 3.85% with three potential targets T1: ₹9.70, T2: ₹9.82, T3: ₹9.96 and Stop-Loss (SL) at SL1: ₹9.57, SL2: ₹9.42, SL3: ₹9.27.
Additionally, we've identified a support level at 9.59 — think of this as a safety net where the price might stop falling and there's also a resistance level at 9.59, which is like a ceiling at which the price might have a hard time breaking through.
After looking at tomorrow's, next week's and next month's share price prediction, you might wonder what this year or next year might hold for Kabra Drugs, we created a specific page for that check here: Kabra Drugs Share Price target for 2024 and 2025
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
As we wrap up, we hope you like our study on Kabra Drugs short term share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyze historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.